Dayton Misfeldt is Director at SUNESIS PHARMACEUTICALS INC (SNSS). They have made 6 open-market trades across 1 company since 2010, most recently 2017-10-27.
CIK 0001461466
3 open-market purchases totalling $8.9M since 2010, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SNSS | 30,456 | $567K |
Shares reported on the most recent Form 4, priced at the 2017-10-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SNSS | BUY | 2017-10-27 | 2017-10-30 | $2.00 | $800K | +24.2% | +28.3% | +105.4% |
| SNSS | BUY | 2015-12-21 | 2015-12-21 | $0.84 | $1.5M | -0.0% | -3.6% | -34.7% |
| SNSS | SELL | 2015-07-24 | 2015-12-21 | $3.46 | $2.2M | -0.0% | -3.6% | -34.7% |
| SNSS | SELL | 2014-08-27 | 2014-08-29 | $7.98 | $2.4M | -0.0% | +1.2% | +1.2% |
| SNSS | SELL | 2014-08-08 | 2014-08-12 | $6.64 | $4.9M | -0.0% | +1.2% | +1.2% |
| SNSS | BUY | 2010-06-30 | 2010-07-01 | $0.28 | $6.7M | -0.0% | +1.2% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.